Ann: CIB announces $30m order, page-47

Seems to be a paywall, thankfully there is a transcript:

Ssome key points:

"The the first part is that our cells continue to operate even after they've been penetrated."

"most invasive is now penetration, and we're delighted to have passed that. So that's got global significance in our view."

"But the right now, we're not tapping the market for more money. We don't need to. We're building our phase three facility. We're we're getting that done so that we can provide trial sales to all of our partners. Um, and in due course, as we go over through future years, then obviously we want to expand that capability to manufacture either directly or through licensing with other manufacturers of battery cells."